# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-187149
Filing Date
2026-04-28
Accepted
2026-04-28 16:19:48
Documents
19
Period of Report
2026-04-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | whwk-20260428.htm iXBRL | DEF 14A | 1216806
2 | GRAPHIC | img96983719_0.jpg | GRAPHIC | 19598
3 | GRAPHIC | img96983719_1.jpg | GRAPHIC | 19598
4 | GRAPHIC | img96983719_2.jpg | GRAPHIC | 19598
5 | GRAPHIC | img96983719_3.jpg | GRAPHIC | 320093
6 | GRAPHIC | img96983719_4.jpg | GRAPHIC | 326209
7 | GRAPHIC | img96983719_5.jpg | GRAPHIC | 2503780
8 | GRAPHIC | img96983719_6.jpg | GRAPHIC | 1826392
| Complete submission text file | 0001193125-26-187149.txt |  | 13470174

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | whwk-20260428.xsd | EX-101.SCH | 14767
22 | EXTRACTED XBRL INSTANCE DOCUMENT | whwk-20260428_htm.xml | XML | 317398

Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38560 | Film No.: 26908150
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)